Lisanti Capital Growth LLC Buys New Shares in Schrodinger, Inc. $SDGR

Lisanti Capital Growth LLC purchased a new stake in shares of Schrodinger, Inc. (NASDAQ:SDGR) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 92,600 shares of the company’s stock, valued at approximately $2,875,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in SDGR. Root Financial Partners LLC purchased a new position in shares of Schrodinger in the third quarter worth $50,000. Sterling Capital Management LLC increased its position in shares of Schrodinger by 843.8% in the 3rd quarter. Sterling Capital Management LLC now owns 1,916 shares of the company’s stock valued at $59,000 after acquiring an additional 1,713 shares during the period. Allworth Financial LP acquired a new position in shares of Schrodinger in the 2nd quarter valued at $86,000. PNC Financial Services Group Inc. raised its stake in Schrodinger by 1,037.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 7,778 shares of the company’s stock worth $88,000 after acquiring an additional 7,094 shares during the last quarter. Finally, Integrated Wealth Concepts LLC purchased a new position in Schrodinger in the 2nd quarter worth $102,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Schrodinger Price Performance

NASDAQ:SDGR opened at $31.52 on Thursday. The company’s fifty day moving average price is $26.55 and its 200-day moving average price is $17.32. Schrodinger, Inc. has a 1-year low of $10.94 and a 1-year high of $34.00. The firm has a market capitalization of $2.33 billion, a P/E ratio of -39.90 and a beta of 1.69.

Schrodinger (NASDAQ:SDGR) last announced its quarterly earnings results on Wednesday, November 4th. The company reported ($0.50) earnings per share for the quarter, topping the consensus estimate of ($0.67) by $0.17. The company had revenue of $64.49 million for the quarter, compared to the consensus estimate of $47.73 million. Schrodinger had a negative return on equity of 18.12% and a negative net margin of 22.02%. The firm’s revenue for the quarter was up 18.7% compared to the same quarter last year. During the same period last year, the firm earned ($0.45) EPS. Equities analysts anticipate that Schrodinger, Inc. will post -1.39 EPS for the current fiscal year.

Insider Transactions at Schrodinger

In other Schrodinger news, insider Karen Akinsanya sold 31,599 shares of the business’s stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $29.37, for a total value of $928,062.63. Following the completion of the transaction, the insider directly owned 69,956 shares of the company’s stock, valued at approximately $2,054,607.72. The trade was a 31.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Yvonne Tran sold 32,000 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $32.85, for a total value of $1,051,200.00. Following the completion of the sale, the executive vice president owned 52,683 shares in the company, valued at approximately $1,730,636.55. This represents a 37.79% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have commented on SDGR. UBS Group lifted their price target on Schrodinger from $19.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 20th. TD Cowen increased their price objective on Schrodinger from $31.00 to $36.00 and gave the company a “buy” rating in a report on Thursday, November 5th. KeyCorp raised their price objective on Schrodinger from $20.00 to $32.00 and gave the stock an “overweight” rating in a research note on Friday, October 16th. Wall Street Zen raised Schrodinger from a “strong sell” rating to a “hold” rating in a report on Saturday, August 8th. Finally, BMO Capital Markets lifted their target price on Schrodinger from $24.00 to $30.00 and gave the stock an “outperform” rating in a report on Monday, October 12th. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $26.67.

Schrodinger Company Profile

Schrödinger, Inc. develops computational software used to support drug discovery and materials research. Its platform applies physics-based modeling, computational chemistry and machine learning to help researchers analyze molecular properties and identify promising candidates. The company’s tools are used by pharmaceutical and biotechnology companies, academic institutions and other research organizations. Alongside software sales and subscriptions, Schrödinger works with partners on drug discovery programs and advances a portfolio of its own therapeutic candidates.